GPR55 and the regulation of glucose homeostasis.

[1]  Peter M. Jones,et al.  GPR55‐dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans , 2016, Diabetes, obesity & metabolism.

[2]  P. Flatt,et al.  Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice , 2016, Diabetologia.

[3]  W. Klapper,et al.  Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer , 2016, Oncotarget.

[4]  Hsi-chi Lu,et al.  Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity , 2016, International Journal of Obesity.

[5]  J. Haybaeck,et al.  GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis , 2016, British journal of pharmacology.

[6]  M. Falasca,et al.  Role of the lysophosphatidylinositol/GPR55 axis in cancer. , 2016, Advances in biological regulation.

[7]  B. Huppertz,et al.  A role for GPR55 in human placental venous endothelial cells , 2015, Histochemistry and Cell Biology.

[8]  C. Hiley,et al.  Biased Signalling Might be the Answer to the Inconsistent Pharmacology of GPR55 , 2015 .

[9]  A. McAinch,et al.  A potential role for GPR55 in the regulation of energy homeostasis. , 2014, Drug discovery today.

[10]  P. Flatt,et al.  Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta‐cells, isolated pancreatic islets and mice , 2013, British journal of pharmacology.

[11]  K. Mackie,et al.  A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice , 2013, Neuropharmacology.

[12]  K. Mackie,et al.  GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination , 2013, PloS one.

[13]  D. Rusakov,et al.  Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses , 2013, Proceedings of the National Academy of Sciences.

[14]  R. Westkaemper,et al.  A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55. , 2013, Journal of molecular graphics & modelling.

[15]  M. Caron,et al.  Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands. , 2011, Biochemistry.

[16]  P. Zimmet,et al.  The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives , 2012, Nature Reviews Endocrinology.

[17]  M. Waldhoer,et al.  The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55 , 2012, British journal of pharmacology.

[18]  M. Malagón,et al.  The atypical cannabinoid O‐1602 stimulates food intake and adiposity in rats , 2012, Diabetes, obesity & metabolism.

[19]  J. Moreno-Navarrete,et al.  The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity , 2012, Diabetes.

[20]  S. Romero-Zerbo,et al.  A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. , 2011, The Journal of endocrinology.

[21]  A. Irving,et al.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. , 2011, Molecular endocrinology.

[22]  M. Storr,et al.  A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[23]  F. Bermúdez-Silva,et al.  The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning? , 2010, Pharmacology Biochemistry and Behavior.

[24]  A. Irving,et al.  A role for L‐α‐lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells , 2010, British journal of pharmacology.

[25]  Marc G Caron,et al.  Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands* , 2009, The Journal of Biological Chemistry.

[26]  A. Irving,et al.  The GPR55 ligand L‐α‐lysophosphatidylinositol promotes RhoA‐dependent Ca2+ signaling and NFAT activation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  K. Mackie,et al.  GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.

[28]  S. Hjorth,et al.  The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.

[29]  A. Yamashita,et al.  Identification of GPR55 as a lysophosphatidylinositol receptor. , 2007, Biochemical and biophysical research communications.

[30]  M. Maj,et al.  Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. , 2006, The Journal of clinical endocrinology and metabolism.

[31]  H. Heng,et al.  Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. , 1999, Brain research. Molecular brain research.

[32]  S. Metz.  Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. , 1986, Biochemical and biophysical research communications.